Keratin-19 (Keratin 19)

01/01/2021 - "Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors."
12/01/2019 - "In the last few years, there has been a growing interest in Cytokeratin 19 (CK19) studies in the cancer research field. "
06/15/2008 - "The aim of this study was to assess the value of CK10 alone or in combination with cytokeratin 19 (CK19) in predicting tumor recurrence after curative resection in HCC patients. "
01/01/2007 - "In an immunohistochemical study, the tumor cells were negative for cytokeratin 19. "
09/01/2003 - "Previous studies have demonstrated that cytokeratin 19 reverse transcriptasepolymerase chain reaction can detect tumor cells even when lymph nodes appear normal histologically. "

10/30/2023 - "Numerous studies have proven the potential of cytokeratin 19 fragment 21-1 (CYFRA 21-1) detection in the (early) diagnosis and treatment monitoring of non-small cell lung cancer (NSCLC). "
01/01/2007 - "The aim of this study was to evaluate the prognostic value of cytokeratin 19 expression in non-small cell lung cancer. "
05/01/2022 - "We retrospectively screened 108 patients with advanced non-small cell lung cancer (NSCLC) treated via S-1 monotherapy and investigated its relationship with cytokeratin 19 fragment (CYFRA 21-1) and CEA pretreatment levels. "
01/17/2017 - "The pooled RR estimates indicated that there is no statistical significance of Cytokeratin 19 fragment level expression in the advanced Non-small Cell Lung Cancer (IIIB+IV) (RR =1.43, 95% CI: 0.85-2.43). "
04/22/2015 - "Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer."

12/31/2022 - "The present study aimed to identify Cytokeratin-19 (CK19) gene profiles that accurately predicted the outcome of breast cancer patients. "
05/28/2008 - "The goal of this study was to identify the origin of Cytokeratin 19 (CK19) and HER-2 signal in PBMC and suggest an approach to enhance techniques involved in detection of CTC in breast cancer patients. "
06/01/2005 - "This study was designed to evaluate expression and clinical significance of cytokeratin 19 (CK19) in bone marrow of patients with breast cancer. "
07/01/1997 - "In this study, we report a new method to detect rare human breast cancer cells, which combines an immunomagnetic separation (IMS) procedure with cytokeratin 19 (CK 19) immunostaining. "
12/31/2022 - "Diagnostic of Cytokeratin-19 Gene Expression in Iranian Breast Cancer Patients."

01/01/1995 - "Cytokeratin-19 estimation may be also helpful in lung cancer staging."
06/11/1999 - "The present study was designed to clarify the mechanism by which some lung cancer cell lines can produce cytokeratin 19 (CK19) fragment and others cannot. "
07/01/1996 - "The aim of our study was to establish the value of serum cytokeratin-19 soluble fragment (Cyfra 21-1) measurement in lung cancer patients. "
09/01/2023 - "Accurate and ultrasensitive detection of cytokeratin 19 fragment (CYFRA21-1) is of vital importance for screening and diagnosis of potential lung cancer patient. "
12/01/2016 - "Serum cytokeratin 19 fragment (CYFRA21-1) has been found to be a useful prognostic marker in lung cancer. "

11/01/2021 - "Comparison of Immunohistochemical Expression of Cytokeratin 19, c-KIT, BerEP4, GATA3, and NUTM1 Between Porocarcinoma and Squamous Cell Carcinoma."
08/01/2012 - "In conclusion, we found cytokeratin 19 to be a helpful marker in the distinction of porocarcinoma from squamous cell carcinoma, although a focal staining pattern can be seen in a third of cases. "
09/01/2008 - "Increased expression of an epidermal stem cell marker, cytokeratin 19, in cutaneous squamous cell carcinoma."
04/01/1998 - "Squamous cell carcinomas of the maxillary sinus arising from pseudostratified ciliated epithelium were highly expressive of cytokeratin 19. "
06/01/1997 - "Recently, the serum fragment of cytokeratin 19 has been measured and found to be a good marker for squamous cell carcinoma. "